Mechanisms of action of peptide immunotherapy for type 1 diabetes : characterising T-cells induced or modified by proinsulin C19-A3
Peptide immunotherapy (PIT) is a specific immunomodulatory treatment aiming to tip the balance from pro8inflammatory attack to restoration of immune tolerance. It has been successfully translated into clinical practice in the field of allergy, stimulating ongoing research in autoimmune diseases incl...
Main Author: | Liu, Yuk-Fun |
---|---|
Other Authors: | Peakman, Mark |
Published: |
King's College London (University of London)
2018
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733448 |
Similar Items
-
Pleiotropic action of proinsulin C-peptid
by: Michał Usarek, et al.
Published: (2012-03-01) -
In vitro effects of insulin and proinsulin C-peptide on human saphenous vein function
by: Mughal, Romana Saher
Published: (2011) -
Peptide immunotherapy in type 1 diabetes
by: Thrower, Sally L.
Published: (2011) -
Characterisation of T cell epitopes of proinsulin in type 1 diabetes
by: Astill, Thomas Patrick
Published: (2002) -
Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
by: Lina Nordquist, et al.
Published: (2008-12-01)